Literature DB >> 23819004

Case report: cranioplasty infection due to Roseomonas gilardii at a university hospital in Turkey.

Gulfem Ece1, Mete Ruksen, Ali Akay.   

Abstract

Roseomonas is a pink-pigmented, nonfermentative, oxidative, Gram-negative coccobacilli that has clinical importance as opportunistic pathogen which can lead to infections especially in immunosuppressed individuals. It is relatively less reported in many centers. These microorganisms are detected after several days growth in culture environment, and typical pink, mucoid colonies are detected. We are reported a case of cranioplasty infection that took place in a patient with with cranial abscess formation due to Roseomonas gilardii at Izmir University School of Medicine Medicalpark Hospital.

Entities:  

Keywords:  R. gilardii; cranioplasty; pink-pigmented bacilli

Mesh:

Year:  2013        PMID: 23819004      PMCID: PMC3696469          DOI: 10.11604/pamj.2013.14.162.2730

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Gilardi and Faur showed a new group of pink-pigmented nonfermentative bacteria and then it was defined by the Centers for Disease Control and Prevention to indicate these bacteriae in 1984 [1]. Roseomonas is a pink-pigmented, nonfermentative, oxidase (+), Gram-negative coccobacilli that has clinical importance as opportunistic bacteria which can lead to infections especially in immunosuppressed individuals. Most infections due to Roseomonas spp. are detected in patients with central venous catheters and underlying disorders. It is less reported in many hospitals because of having little experience in identification and less clinicians dealing with these infections [2, 3]. They are detected after several days of growth in culture environment, characteristic pink, mucoid colonies are observed [4]. Although some strains were isolated from environment, the natural source of Roseomonas spp. is still a challenge. The clinical specimens in which the microorganism was isolated include wounds, exudates, abscesses and genitourinary specimens. Besides, infection can be related with peritoneal dialysis and vertebral osteomyelitis. The clinical importance of these isolates is an essential issue in individuals with underlying disorders such as cancer and diabetes and in a study that reviewed of 35 cases from which Roseomonas strains were isolated, 60% were found to be related with disease [5]. We are reported a case of wound infection that took place in a patient with with cranial abscess formation due to Roseomonas gilardii at Izmir University School of Medicine Medicalpark Hospital.

Patient and observation

30-year old male patient had decompression operation due to cranial fracture 15 years ago. He had cranioplasty operation 12 years ago. Two weeks ago he complained of headache, and abscess formation on the frontal bone (Figure 1). The abscess formation was surgically drained at the Neurosurgey Department and sent to Izmir University School of Medicine Clinical Microbiology Laboratory. The specimen was cultivated on blood agar, chocolate agar and eosin metylene blue agar. After two days of incubation at 37°C; pink mucoid colonies were detected on blood agar. The identification of the strain was carried out by automatized Vitek 2.0 (Biomerieux, France). The culture reported the isolate as Roseomonas gliardii (Figure 2). The isolate was susceptible to amikacin, imipenem, levofloxacin, tigecycline, ciprofloxacin, and resistant to meropenem and tazobactam/piperacillin. Then his complaints continued and he underwent neurosurgical operation and cranioplasty was removed the from the cranium (Figure 3, Figure 4). The patient recovered thereafter.
Figure 1

Abscess formation on the frontal bone

Figure 2

Roseomonas gliardii on blood agar (pink-mucoid colony)

Figure 3

Removal of the cranioplasty

Figure 4

The cranioplasty

Abscess formation on the frontal bone Roseomonas gliardii on blood agar (pink-mucoid colony) Removal of the cranioplasty The cranioplasty

Discussion

Roseomonas is a Gram-negative bacilli that is known as pink-pigmented bacilli and classified in groups I through IV by Centers for Disease Control and Prevention [6]. Infection usually takes place in patients with underlying medical illness such as malignancy, acquired immune deficiency syndrome, chronic renal disease or diabetes mellitus. We reported a patient with Roseomonas giliardii infection after cranioplasty operation that took place twelve years ago. De et al analyzed 36 cases of bacteremia or catheter-related infection caused by Roseomonas species, a group of pink, slimy, waterborne, Gram-negative coccobacilli.. Twenty nine (81%) of the cases were symptomatic, with fever being the most common symptom. Twenty (56%) of the infections were caused by a single microorganism. Six cases (17%) had catheter colonization, and five of them removed catheter to stop infection. All patients healed with empirical antibiotic treatment. The antibiotic susceptibility pattern of these strains and other reported series showed that Roseomonas species are susceptible to amikacin and imipenem and frequently susceptible to ciprofloxacin and ticarcillin, but essentially nonsusceptible to ceftazidime and cefepime. This result may facilitate treatment for infections due to Roseomonas species [7]. In our case similarly the isolate was susceptible to imipenem and amikacin; and resistant to ceftazidime. Wang et al evaluated the database of the Bacteriology Laboratory at the National Taiwan University Hospital to identify patients with infections caused by Roseomonas species during a decade. Twenty patients had cultures positive for Roseomonas species. The authors concluded that Roseomonas species can cause infection in children and adults independent of immunity [8]. Nolan et al report the first case of ventriculitis caused by R. Gilardii in a 54-year-old man with a subarachnoid haemorrhage secondary to a vertebral artery aneurysm [3]. In our case report the patient underwent decompression operation and that may be the major risk factor. Singal et al reported the first case of left ventricular assist device infection secondary to Roseomonas. The patient was a 48-year-old man with nonischemic cardiomyopathy and severe aortic regurgitation. He underwent implantation and during transplantion, a collection of granulation tissue was detected behind the ascending aorta. Drainage of this clinical specimen underwent culture and grew pink mucoid colonies and the culture reported as Roseomonas species. The isolate was resistant to trimethoprim-sulfamethoxazole, ceftazidime, and piperacillin-tazobactam and intermediate susceptibility to cefuroxime [9]. The isolate was susceptible to cefazolin, cefotetan, ceftriaxone, gentamicin, amikacin, doxycycline, ciprofloxacin, aztreonam, and meropenem. In our case report the isolate was susceptible to ciprofloxacin; but resistant to meropenem and there was a history of cranioplasty operation.

Conclusion

In our case we reported a patient with Roseomonas gilardii infection cranioplasty operation that took place more than a decade ago. This case emphasizes the potential for organisms that cause infection indwelling catheters particularly in immunosuppressed ones and this should be kept in mind.
  8 in total

1.  An initial appraisal of the clinical significance of Roseomonas species associated with human infections.

Authors:  M Struthers; J Wong; J M Janda
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

2.  Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates.

Authors:  Ching-Min Wang; Chih-Cheng Lai; Che-Kim Tan; Yu-Chuang Huang; Kuei-Pin Chung; Meng-Rui Lee; Kao-Pin Hwang; Po-Ren Hsueh
Journal:  Diagn Microbiol Infect Dis       Date:  2011-12-29       Impact factor: 2.803

Review 3.  Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhage.

Authors:  Jason S Nolan; Ken B Waites
Journal:  J Infect       Date:  2005-04       Impact factor: 6.072

4.  Roseomonas gilardii infection: case report and review.

Authors:  Navkiran K Shokar; Gurjeet S Shokar; Jamal Islam; Alvah R Cass
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Roseomonas infection associated with a left ventricular assist device.

Authors:  Amit Singal; Preeti N Malani; Larry J Day; Francis D Pagani; Nina M Clark
Journal:  Infect Control Hosp Epidemiol       Date:  2003-12       Impact factor: 3.254

6.  Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer.

Authors:  Indra Dé; Kenneth V I Rolston; Xiang Y Han
Journal:  Clin Infect Dis       Date:  2004-05-07       Impact factor: 9.079

7.  Roseomonas gilardii subsp rosea, a pink bacterium associated with bacteremia: the first case in Thailand.

Authors:  Somporn Srifuengfung; Prasit Tharavichitkul; Satchana Pumprueg; Chanwit Tribuddharat
Journal:  Southeast Asian J Trop Med Public Health       Date:  2007-09       Impact factor: 0.267

8.  Pseudomonas mesophilica and an unnamed taxon, clinical isolates of pink-pigmented oxidative bacteria.

Authors:  G L Gilardi; Y C Faur
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

  8 in total
  3 in total

1.  Infectious Spondylitis with Bacteremia Caused by Roseomonas mucosa in an Immunocompetent Patient.

Authors:  Kyong-Young Kim; Jaehyung Hur; Wonyong Jo; Jeongmin Hong; Oh-Hyun Cho; Dong Ho Kang; Sunjoo Kim; In-Gyu Bae
Journal:  Infect Chemother       Date:  2015-09-30

2.  Two Cases of Bacteremia Due to Roseomonas mucosa.

Authors:  Yu Kyung Kim; Jung Suk Moon; Kyung Eun Song; Won Kil Lee
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464

Review 3.  Roseomonas gilardii in patient with leukemia and acute appendicitis: case report and review.

Authors:  Francesk Mulita; Nikoleta Oikonomou; Athanasios Provatidis; Agelos Alexopoulos; Ioannis Maroulis
Journal:  Pan Afr Med J       Date:  2020-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.